Avata Biosciences Holdings
Develops cannabinoid medicines for patients with epilepsy and other neurological diseases
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Avata Biosciences Holdings
Avata Biosciences develops pharmaceutical-grade cannabinoid medicines using a process that turns water-insoluble active ingredients into water-soluble powder. Its products include capsule and aqueous-solution formulations, with programs for adult and pediatric focal epilepsy and schizophrenia.
The company is a clinical-stage pharmaceutical business. It lists offices in London, Phoenix and Carlton, Australia, and announced a co-development and licensing agreement for Japan and parts of Asia in 2025.
Product: Develops prescription cannabinoid medicines in capsule and aqueous-solution formulations for neurological conditions.
Jobs at Avata Biosciences Holdings
More biotech & pharma companies
Avaxmed
Develops solid-dose vaccine and medication manufacturing and needle-free delivery technology for human and veterinary useAviadobio
Develops gene therapies for patients with neurodegenerative diseases, including disorders affecting the brain and retinaAvianta Pharma
Licenses and supplies essential medicines to online pharmacy networksAvonchem Diagnostics
Supplies chemicals, reagents, solvents and diagnostic tests to pharma, manufacturing and healthcare buyers in the UKNew on EvolcAxovia Therapeutics
Gene therapies for people with ciliopathies, including Bardet-Biedl syndrome and genetic obesityYoung companyNew on EvolcAzadyne
Pre-clinical drug developer targeting tRNA modification pathways to treat autoimmune and other diseasesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
